Information about Pharmix
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0421.297.724

VAT liability
Yes
Established
18-02-1981
Last balance sheet year
2024
Company size
Small 1 FTE
Principal activity
Manufacture of condiments and seasonings
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Pharmix

2024 2023 2022 2021
Profit/Loss 274,428 885 % -34,951 -17 % -30,000 -803 % 4,267
Equity 126,648 143 % 52,220 -40 % 87,171 -90 % 917,171
Gross margin 478,643 789 % 53,852 1 % 53,385 -50 % 106,119

Publications from Pharmix

Date Publication
30-07-2024 Resignations - Appointments (NL)
28-06-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Designation (NL)
06-06-2023 Resignations - Appointments (NL)
03-11-2022 Resignations - Appointments (NL)
04-02-2022 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Pharmix?
The VAT number of Pharmix is BE 0421.297.724.
Wat is the PEPPOL ID of Pharmix?
The PEPPOL ID of Pharmix is 0208:0421297724. Log in or start a free trial to see the full overview.
When was Pharmix founded?
Pharmix was founded on 18-02-1981.
What is the address of Pharmix?
The current registered office of Pharmix is located at Verbrand-Hofstraat 26, 2990 Wuustwezel.
When was the last time Pharmix filed their annual financial statements?
The most recent financial statements of Pharmix were filed on 10-06-2025.
How many employees does Pharmix have?
There are 1 FTEs working at Pharmix according to the staff figures in the most recent financial statements.
What is the annual turnover of Pharmix?
At the time of its most recent financial statements, Pharmix did not publish any turnover figures. Pharmix reported a gross margin of €478,642.56.